tradmap

NHI Financials National Health Investors Inc

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Financial health

  • Total debt ($1.2B) exceeds cash ($20M); net debt is $1.1B.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 119.4% of earnings.
  • The dividend has declined 2.7% per year over the past 5 years.
Revenue & net income
$0 $93M $185M 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 139% 278% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 10% 20% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$550M -$188M $174M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $750M $1B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$626M -$51M $524M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $80M $142M 0.0% 0.0% 9.3% 5.1% -$57M $1.2B $20M
2024 $54M $138M 0.0% 0.0% 10.1% 5.3% $50M $1.1B $24M
2023 $49M $136M 0.0% 0.0% 10.8% 5.5% $135M $1.1B $22M
2022 $36M $66M 0.0% 0.0% 5.2% 2.6% $174M $1.1B $19M
2021 $0 $112M 7.4% 3.9% $161M $1.2B $37M
2020 $0 $185M 12.2% 5.9% $115M $1.5B $43M
2019 $160M 10.7% 5.3% $4M $1.4B $5M
2018 $154M 11.1% 5.6% $60M $1.3B $5M
2017 $159M 12.1% 6.3% $22M $1.1B $3M
2016 $152M 12.5% 6.3% -$218M $1.1B $5M
2015 $149M 13.1% 7.0% $40M $914M $13M
2014 $102M 9.8% 5.1% -$407M $863M $3M
2013 $106M 13.9% 7.3% -$550M $617M $11M
2012 $91M 19.8% 12.9% -$24M $203M $9M
2011 $81M 18.3% 14.0% $1M $97M $16M

Valuation over time

How the market has priced NHI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 20.7 41.4 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 42.3 84.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 3.3 6.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is NHI growing its revenue and profit?

See the revenue and net-income charts above for National Health Investors Inc's multi-year trend.

How much debt does NHI have?

As of FY2025, National Health Investors Inc reported $1.2B of total debt against $20M of cash.

What is NHI's profit margin?

In FY2025, gross margin was —, operating margin —, and net margin 177.6%.

What is NHI's P/E ratio?

As of Sep '26, National Health Investors Inc traded at a price-to-earnings ratio of about 24.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.